PGIMER Human Genetics
--Sharing is Caring--

PGIMER Human Genetics & Biotechnology Research Fellow Job

PGIMER Human Genetics & Biotechnology Research Fellow Job. MSc Biotech / Human Genetics & Biochemistry Candidates Apply. Research jobs at PGIMER. PGIMER is hiring MSc candidates for SRF Job. Interested and eligible candidates can check out all the details:

This job expires in :

- Advertisement -

-70Days -13Hours -17Minutes -43Seconds

PGIMER Vacancy Details

Postgraduate Institute of Medical Education & Research
Sector-12-A, Chandigarh – 160012

Name of Job: Senior Research Fellow (SRF)

No. of Posts: 01 position

Name of the Project: “Designing a comprehensive diagnostic NGS panel for inherited bleeding disorders to aid carrier screening and prenatal diagnosis”

Application Procedure for PGIMER Vacancy:

Interested applicants might submit their application to the office of the Department of
Haematology latest by 12 noon on 16.7.2020. The interview will certainly be held in the office of Dr Reena Das as well as candidates are requested to be present with the relevant original certifications as well as a thesis. The interview will certainly be held on 16.7.2020 from 2.00 pm onwards as well as no TA/DA will certainly be admissible for attending the interview. Candidates who will not be able to travel must send their application via e-mail ([email protected]) and also a telephonic interview will certainly be held at the same time.

See Also
DRDO Graduate Apprentice Recruitment 2020 - BSc / B.Tech Food Tech Apply

Essential Qualifications: MSc. Biotechnology / Human Genetics / Biochemistry with two at least two years of research experience.

Remuneration: Rs 35,000/- plus HRA consolidated.

View Notification Below

Editor’s Note: PGIMER Human Genetics & Biotechnology Research Fellow Job. Please make sure that you are subscribed to the Biotecnika Times Newsletter and our YouTube channel to be notified of all of the latest in the industry. Follow us on all of our social media like Twitter, Facebook and Instagram.


Comments are closed.